These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9303588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
    Robins Wahlin TB, Lundin A, Dear K.
    Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
    [Abstract] [Full Text] [Related]

  • 3. A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease.
    van Walsem MR, Sundet K, Retterstøl L, Sundseth Ø.
    J Clin Exp Neuropsychol; 2010 Jul; 32(6):590-8. PubMed ID: 19916101
    [Abstract] [Full Text] [Related]

  • 4. A comparison of two brief screening measures of cognitive impairment in Huntington's disease.
    Mickes L, Jacobson M, Peavy G, Wixted JT, Lessig S, Goldstein JL, Corey-Bloom J.
    Mov Disord; 2010 Oct 15; 25(13):2229-33. PubMed ID: 20721924
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
    Foroud T, Siemers E, Kleindorfer D, Bill DJ, Hodes ME, Norton JA, Conneally PM, Christian JC.
    Ann Neurol; 1995 May 15; 37(5):657-64. PubMed ID: 7755361
    [Abstract] [Full Text] [Related]

  • 7. Evidence of presymptomatic cognitive decline in Huntington's disease.
    Diamond R, White RF, Myers RH, Mastromauro C, Koroshetz WJ, Butters N, Rothstein DM, Moss MB, Vasterling J.
    J Clin Exp Neuropsychol; 1992 Nov 15; 14(6):961-75. PubMed ID: 1452640
    [Abstract] [Full Text] [Related]

  • 8. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease.
    Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM.
    Mov Disord; 2010 Feb 15; 25(3):401-4. PubMed ID: 20108371
    [Abstract] [Full Text] [Related]

  • 9. Assessment of simple movements reflects impairment in Huntington's disease.
    Saft C, Andrich J, Meisel NM, Przuntek H, Müller T.
    Mov Disord; 2006 Aug 15; 21(8):1208-12. PubMed ID: 16700032
    [Abstract] [Full Text] [Related]

  • 10. Phonemic fluency deficits in asymptomatic gene carriers for Huntington's disease.
    Larsson MU, Almkvist O, Luszcz MA, Wahlin TB.
    Neuropsychology; 2008 Sep 15; 22(5):596-605. PubMed ID: 18763879
    [Abstract] [Full Text] [Related]

  • 11. Episodic memory impairment in Huntington's disease: a meta-analysis.
    Montoya A, Pelletier M, Menear M, Duplessis E, Richer F, Lepage M.
    Neuropsychologia; 2006 Sep 15; 44(10):1984-94. PubMed ID: 16797615
    [Abstract] [Full Text] [Related]

  • 12. [Executive dysfunction in Huntington's disease].
    Redondo Vergé L, Brown RG, Chacón J.
    Rev Neurol; 2006 Sep 15; 32(10):923-9. PubMed ID: 11424047
    [Abstract] [Full Text] [Related]

  • 13. [A neuropsychological study of Huntington's disease in families in Antioquia, Colombia].
    Arango-Lasprilla JC, Iglesias-Dorado J, Moreno S, Lopera F.
    Rev Neurol; 2006 Sep 15; 37(1):7-13. PubMed ID: 12861500
    [Abstract] [Full Text] [Related]

  • 14. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
    Fragassi NA, Stanzione M, Angelini R, Di Maio L.
    Acta Neurol (Napoli); 1992 Sep 15; 14(4-6):530-6. PubMed ID: 1293994
    [Abstract] [Full Text] [Related]

  • 15. Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease.
    Blekher TM, Yee RD, Kirkwood SC, Hake AM, Stout JC, Weaver MR, Foroud TM.
    Vision Res; 2004 Oct 15; 44(23):2729-36. PubMed ID: 15358067
    [Abstract] [Full Text] [Related]

  • 16. Normal and pathological aging of attention in presymptomatic Huntington's, Huntington's and Alzheimer's Disease, and nondemented elderly subjects.
    Peretti CS, Ferreri F, Blanchard F, Bakchine S, Peretti CR, Dobrescu A, Chouinard VA, Chouinard G.
    Psychother Psychosom; 2008 Oct 15; 77(3):139-46. PubMed ID: 18277060
    [Abstract] [Full Text] [Related]

  • 17. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
    Hahn-Barma V, Deweer B, Dürr A, Dodé C, Feingold J, Pillon B, Agid Y, Brice A, Dubois B.
    J Neurol Neurosurg Psychiatry; 1998 Feb 15; 64(2):172-7. PubMed ID: 9489526
    [Abstract] [Full Text] [Related]

  • 18. [Relation between frontal lobe blood flow and cognitive performance in Huntington's disease].
    Gómez-Tortosa E, Arias Navalón JA, del Barrio Alba A, Barroso Fernández T, Pardo Pardo C, Sánchez Martín JA, García Yébenes J.
    Neurologia; 1996 Feb 15; 11(7):251-6. PubMed ID: 8974425
    [Abstract] [Full Text] [Related]

  • 19. Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease.
    Finke K, Bublak P, Dose M, Müller HJ, Schneider WX.
    Brain; 2006 May 15; 129(Pt 5):1137-51. PubMed ID: 16504973
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease.
    Wolf RC, Sambataro F, Vasic N, Wolf ND, Thomann PA, Landwehrmeyer GB, Orth M.
    Exp Neurol; 2011 Oct 15; 231(2):214-22. PubMed ID: 21726553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.